{"doi":"10.1098/rsif.2025.0138","title":"Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases","abstract":"<jats:p>The complement system, a vital component of innate immunity, is indispensable to our immune defence mechanisms against microbial infections. Acting as a surveillance mechanism, it identifies and eliminates pathogens by activating several complement components and associated signalling pathways, which are also implicated in various diseases and disorders. Beyond its defensive role, the complement system has emerged as a promising target for vaccine development in therapeutic and preventive regimens, offering new vaccine strategies to combat non-infectious and infectious diseases. Activation of the complement pathways by various natural and synthetic adjuvants enhances protective immune responses, highlighting its utility in vaccine design. This approach could be useful for targeting autoimmune diseases, infectious diseases, cancer and neurological disorders.</jats:p>","journal":"Journal of The Royal Society Interface","year":2025,"id":601244,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1541580,"name":"Buddhadev Mallick","orcid":null,"position":1,"is_corresponding":false},{"id":1042578,"name":"Kutty Selva Nandakumar","orcid":"0000-0001-7790-8197","position":2,"is_corresponding":false},{"id":491811,"name":"Akhilesh Kumar Shakya","orcid":"0000-0002-8907-7009","position":3,"is_corresponding":false},{"id":1541579,"name":"Nur Hendri Wahyu Firdaus","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases","abstract":"<jats:p>The complement system, a vital component of innate immunity, is indispensable to our immune defence mechanisms against microbial infections. Acting as a surveillance mechanism, it identifies and eliminates pathogens by activating several complement components and associated signalling pathways, which are also implicated in various diseases and disorders. Beyond its defensive role, the complement system has emerged as a promising target for vaccine development in therapeutic and preventive regimens, offering new vaccine strategies to combat non-infectious and infectious diseases. Activation of the complement pathways by various natural and synthetic adjuvants enhances protective immune responses, highlighting its utility in vaccine design. This approach could be useful for targeting autoimmune diseases, infectious diseases, cancer and neurological disorders.</jats:p>","is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"40592462","pmcid":null,"openalex_id":"https://openalex.org/W4411852425","authors":[],"funders":[],"total_grants":0,"fwci":0.8307,"citation_percentile":0.71636984,"influential_citations":0,"citation_trend":[{"year":2025,"count":1},{"year":2026,"count":1}],"oa_status":"hybrid","license":"cc-by","oa_locations":[{"url":"https://doi.org/10.1098/rsif.2025.0138","host_type":"journal"},{"url":"https://doi.org/10.1098/rsif.2025.0138","host_type":"publisher"},{"url":"https://royalsocietypublishing.org/doi/pdf/10.1098/rsif.2025.0138","host_type":"publisher"},{"url":"https://royalsocietypublishing.org/doi/full-xml/10.1098/rsif.2025.0138","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/40592462","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12212990","host_type":"repository"}],"fields_of_study":["Complement system in diseases","Immune Cell Function and Interaction","SARS-CoV-2 and COVID-19 Research","Humans","Complement System Proteins","Animals","Vaccines","Immunity, Innate","Communicable Diseases","Autoimmune Diseases","Neoplasms","Complement Activation"],"mesh_terms":["Animals","Autoimmune Diseases","Communicable Diseases","Complement System Proteins","Complement Activation","Humans","Immunity, Innate","Neoplasms","Vaccines"],"keywords":["Immunology","Innate immune system","Complement system","Immune system","Immunity","Complement receptor","Infectious disease (medical specialty)","Medicine","Classical complement pathway","Vaccination","Biology","Disease","adjuvants","autoimmunity","cancer","infections","neurological disorders","vaccine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T15:38:15.477327Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}